LUM001 in paediatric patients with cholestasis

• Research type

  Research Study

• Full title

  Open label study of the efficacy and long term safety of LUM001, an Apical Sodium dependent Bile Acid transporter Inhibitor (ASBTi), in the treatment of cholestatic liver disease in pediatric patients with progressive familial intrahepatic cholestasis.

• IRAS ID

  139989

• Contact name

  Richard Thompson

• Contact email

  richard.j.thompson@kcl.ac.uk

• Sponsor organisation

  Lumena Pharmaceuticals UK

• Eudract number

  2013-003833-14

• REC name

  London - West London & GTAC Research Ethics Committee

• REC reference

  13/LO/1860

• Date of REC Opinion

  30 Jan 2014

• REC opinion

  Further Information Favourable Opinion